Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Earnings

Q3 2021		Est.		Actual		Surprise
EPS		-0.480		-0.400		0.0800
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Cullinan Oncology Questions & Anwsers

How do I buy Cullinan Oncology (CGEM) stock?

You can purchase shares of Cullinan Oncology (NASDAQ: CGEM) through any online brokerage.

View our list of the best stock brokerages.

Who are Cullinan Oncology's (CGEM) competitors?

There are no as such competitors for Cullinan Oncology.

What is the target price for Cullinan Oncology (CGEM) stock?

The latest price target for Cullinan Oncology (NASDAQ: CGEM) was reported by Morgan Stanley on June 7, 2021. The analyst firm set a price target for 43.00 expecting CGEM to rise to within 12 months (a possible 164.53% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Cullinan Oncology (CGEM)?

The stock price for Cullinan Oncology (NASDAQ: CGEM) is $16.255 last updated Today at 2:46:32 PM.

Does Cullinan Oncology (CGEM) pay a dividend?

There are no upcoming dividends for Cullinan Oncology.

When is Cullinan Oncology (NASDAQ:CGEM) reporting earnings?

Cullinan Oncology’s $Q3 earnings are confirmed for after-market on November 9, 2021.

Is Cullinan Oncology (CGEM) going to split?

There is no upcoming split for Cullinan Oncology.

What sector and industry does Cullinan Oncology (CGEM) operate in?

Cullinan Oncology is in the sector and industry. They are listed on the NASDAQ.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD